Antitumormittel
European patent · EP0239362 · Deleted
Register entry
- Publication number
- EP0239362
- Application number
- EP87302525
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 24, 1987
- Published
- Sep 30, 1987
- Granted
- Dec 4, 1991
- Deleted
- Mar 23, 2007
- Reason
- Maximum term reached
- IPC classes
- C07D 239/88 (2006.01)C07D 401/12 (2006.01)C07D 409/12 (2006.01)A61K 31/505 (2006.01)
- Priority
- GB A 8607683 27.03.1986
- Filing language
- English
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 30, 2007
Maximum term reached
Published in +pat+ No 8 in 2007
- Oct 30, 1998
Address changed
- Owner
- Zeneca Limited, Imperial Chemical House Millbank, London SW1P 3JF, United Kingdom, National Research Development, Corporation, 101 Newington Causeway, London SE1 6BU, United Kingdom → National Research Development Corporation, 10 Fleet Place, London EC4M 7SB, United Kingdom, Zeneca Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom
Published in PIDTJ No 20 in 1998
- Jan 15, 1992
Granted
Published in PIDTJ No 1 in 1992
Parties
Holder
Inventor
Hughes, Leslie Richard
Macclesfield, Cheshire, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.